Atlas Trials

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

Clinical trial NCT06111885 · RECRUITING

Trial details

NCT number
NCT06111885
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Stone
Start date
2024-10-01
Primary completion
2027-06-30
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.